NCT03858972 2021-07-30
CONTESSA 2
Odonate Therapeutics, Inc.
Phase 2 Terminated
Clinical Trials
4 trialsNCT03952325 2021-07-30
CONTESSA TRIO
Odonate Therapeutics, Inc.
Phase 2 Terminated
NCT01221870 2012-07-24
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Genta Incorporated
Phase 2 Unknown
NCT01609127 2012-06-01
Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
Genta Incorporated
Phase 2 Unknown